
This multicenter study of 43 consecutive patients with severe AS reported the outcomes of #TAVR with a novel transfemoral, self-expanding #THV - the #JenaValve Trilogy jacc.org/doi/10.1016/j.jcin.… #JACCINT #vhdAS


This multicenter study of 43 consecutive patients with severe AS reported the outcomes of #TAVR with a novel transfemoral, self-expanding #THV - the #JenaValve Trilogy jacc.org/doi/10.1016/j.jcin.… #JACCINT #vhdAS

DanGer Shock! The first temporary mechanical support device shown to reduce mortality in patients with cardiogenic shock but there is an increased risk of complications. @ShashankSinhaMD @ShelleyZieroth @JasonKatzMD @thiele_holger @DrDamluji @agtruesdell @Cardio_Girl

🔥out now —> here’s our new paper from the MyBiopsy-HF study — enjoy !👉🏻Etiologies and predictors of mortality in an all-comer population of patients with non-ischemic heart failure | Clinical Research in Cardiology link.springer.com/article/10…

The #ApolloEU #trial is now training and initiating trial centers in #Germany in December 2023. A new perspective for patients not suitable for heart surgery and #Mitralvalve TEER procedures. Initial US safety data very promising! More information Heartvalves@unimedizin-Mainz.de

Happy to discuss results about catheter-directed treatment #cdt from our presented socio-economic model with leaders in the field of #pulmonaryembolism and the current president of the #PERTconsortium #aha2023 @RosovskyRachel #timothymorris @StavrosKonstan7

Worldwide first commercial #EVOQUE case today at #HeartvalveCenter #Mainz @UnimedizinMainz closing the loop from interventional innovation to clinical reality a result of robust science a fantastic newly enhanced heart team. @PhilippLurz @vonBardelebenRS

News in EHJ: Promises and challenges of targeting anti-CXCR3 autoantibodies in cardiovascular disease! academic.oup.com/eurheartj/a… #cardioprotective #therapy #autoantibodies #G-protein #receptors #cardiotwitter @escardio @ESC_journals

First implant worldwide of #Topaz transcatheter Tricuspid replacement in torrential TR in comb with pacemaker lead at Heart Valve Center in #Mainz and new in class 4D ICE to be shown at #EACTS in Vienna and #TCT in #SanFrancisco @vonBardelebenRS linkedin.com/posts/von-barde…

Donnerstag, 11h, Saal 12! AG44 goes DGK FT23!

How come that noise exposure worsens outcomes post MI? Here‘s our new translational paper how environmental stress promotes vascular inflammation and deterioration of cardiac function @tmuenzel @OmarHahad @dzhk_germany academic.oup.com/cardiovascr…

Our recent study demonstrated a considerable impact of COVID-19 on adverse outcomes of patients with #pulmonaryembolism in 2020, which should guide attention to this special population. https://t.co/WTfdEfBLpq @EuroRespSoc @escardio @DIVI_eV @UnimedizinMainz